House filed record · 2025
Filed under Gilbert Cisneros · House document 20029026
Disclosures are reported transactions, not verified real-time portfolio holdings.
Use the House document as primary evidence and the rows below as a structured navigation aid.
The filer, reported account owner, transaction and filing dates, asset label, and disclosed amount form.
Current holdings, cost basis, realized profit, investment intent, or misconduct.
Primary evidence
Document 20029026 is displayed from the House Clerk inside this research page. The structured rows below are our reading of the filed record, not a replacement for it.
The embedded document is served by the U.S. House Clerk. If your browser does not display PDFs inline, use “Verify on House.gov.”
Our structured reading
Rows preserve the reported owner and filed amount form. Compare any row against the document above.
Rep. Gilbert Cisneros disclosed that the filer purchased · $1,001 – $15,000 · Banks & Insurers
View transaction source status →Rep. Gilbert Cisneros disclosed that the filer sold · $1,001 – $15,000
View transaction source status →Rep. Gilbert Cisneros disclosed that the filer purchased · $15,001 – $50,000 · Pharma & Biotech
View transaction source status →Rep. Gilbert Cisneros disclosed that the filer partially sold · $1,001 – $15,000 · Banks & Insurers
View transaction source status →Rep. Gilbert Cisneros disclosed that the filer partially sold · $15,001 – $50,000 · Software & Internet
View transaction source status →Rep. Gilbert Cisneros disclosed that the filer purchased · $15,001 – $50,000 · Software & Internet
View transaction source status →Rep. Gilbert Cisneros disclosed that the filer purchased · $1,001 – $15,000 · Software & Internet
View transaction source status →Rep. Gilbert Cisneros disclosed that the filer partially sold · $1,001 – $15,000 · Pharma & Biotech
View transaction source status →Rep. Gilbert Cisneros disclosed that the filer purchased · $250,001 – $500,000
View transaction source status →Rep. Gilbert Cisneros disclosed that the filer partially sold · $15,001 – $50,000 · Pharma & Biotech
View transaction source status →Research journey
Put this document in context without treating one filing as a current portfolio or a conclusion about the filer.